Identifying R&D outliers

Nature Reviews Drug Discovery

Volumn 10, Issue 9, 2011, Pages 653-654

  Tollman, Peter ^a   Morieux, Yves ^a   Murphy, Jeanine Kelly ^a   Schulze, Ulrik ^a  

^a BOSTON CONSULTING GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; CAPITAL; DRUG APPROVAL; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; HIGH THROUGHPUT SCREENING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

DRUG INDUSTRY; EFFICIENCY, ORGANIZATIONAL; RESEARCH;

EID: 80052204248     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd3555     Document Type: Article

References (2)

1. Paul, S. M. et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nature Rev. Drug Discov. 9, 203-215 (2010).
2. Morgan Stanley Research Europe. Pharmaceuticals: Exit Research and Create Value (29 Jan 2010).